Novo Nordisk, Evotec Link Around Chronic Kidney Disease

Pair Will Jointly Identify And Develop New CKD Targets

 
• By Sten Stovall

Novo Nordisk and Evotec will identify and develop novel drugs for treating chronic kidney disease, using datasets of CKD patients provided by the Danish group and from other sources.

Kidneys
Move underscores Novo Nordisk’s move into adjacent cardio-renal-metabolic areas • Source: Shutterstock

More from Deals

More from Business